Sign in
Taking people in United StatesNo phase

AI noise reduction in hearing aids for people with hearing loss

Tests AI noise reduction in hearing aids for adults with hearing loss.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
AI Noise Reduction in Phonak Hearing Aids
Status
Recruiting
People taking part
500 people, planned
Started
24 Apr 2025
Expected to end
1 Jan 2027
Type of study
Interventional, 2 groups
Treatments tested
  • DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction
Record updated
6 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with hearing loss, with or without hearing aids, or with a cochlear implant in one ear. It tests noise reduction in a hearing aid that uses artificial intelligence.

Age
18 Years to 110 Years
Sex
All sexes
Disease stage
Hearing loss. People who do not use hearing aids, people who use hearing aids, and people with a cochlear implant in one ear and a hearing aid in the other ear can join.
Earlier treatment
People with a cochlear implant must have it in one ear only and use a hearing aid in the other ear.

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patients with hearing impairment not using hearing aids
  • Individuals with hearing impairment currently using hearing aids
  • Cochlear implant patients with a single-sided implant (using a hearing aid in the opposite ear)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 110 years old?

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesContact: Clinical Research Study CoordinatorTaking people

About the trial

What the trial wants to find out

The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.

The 2 groups in the trial

  • Hearing Aid onlyTreatment being tested

    Patients with hearing impairment who do not have a Cochlear implant

    Treatment: DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction

  • Cochlear Implant with Hearing AidTreatment being tested

    Patients with hearing impairment who have a single-sided implant (using a hearing aid on the opposite ear)

    Treatment: DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of Artificial Intelligence Based Noise Reduction in Phonak Hearing Aid on Patients With Hearing Impairment and Cochlear Implants
Plain-language title
AI noise reduction in hearing aids for people with hearing lossGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06743295, who can take part
Record updated
6 February 2026